Proper pullet vaccination underpins the protection of layers and broiler breeders during the rearing phase. When done correctly, it stabilises egg ...

Novo Nordisk launched an oral formulation of its peptide-based GLP-1 agonist Wegovy (semaglutide) in the US a few weeks ago, claiming a lead in a category that until then was made up mainly by ...

According to research published in the Aesthetic Surgery Journal, the mortality rate of BBL surgery was once estimated at 1 in 3,000, making it the highest fatality rate of any cosmetic procedure.

MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...

The OriGAMI-4 trial reveals subcutaneous Rybrevant's 45% response rate in metastatic head and neck cancer patients after ...

Researchers at Stanford University, in collaboration with scientists at the German Cancer Institute, have shown for the first ...

The FDA has approved three new pediatric indications for somapacitan-beco, a once-weekly, long-acting growth hormone injection, according to a press release issued by Novo Nordisk.Somapacitan-beco ...

Suchan still needed chemotherapy and radiation, but Salgia credits Rybrevant for shrinking her tumors 60 to 70%. It specifically targets her cancer cells and revs up the immune system. For a year and ...

Risankizumab showed high rates of clinical remission and endoscopic response when administered as subcutaneous induction therapy for moderate to severe CD.

New specialty pharmacy and infusion suite combines compassionate nursing and infusion expertise for patients managing ...

Computer science is the study and development of the protocols required for automated processing and manipulation of data. This includes, for example, creating algorithms for efficiently searching ...

NEW YORK – The European Commission on Monday approved Johnson & Johnson's subcutaneous Rybrevant (amivantamab) in two new dosing schedules as a first-line treatment for patients with advanced ...